Felix Ehret

#EANO2025 comes to an end - it was a fantastic conference, thanks to everyone who participated and made it possible! See you next year in Rome! @eanoassociation.bsky.social @maxmastall.bsky.social @mj-mair.bsky.social @galldiks.bsky.social @profajchalmers.bsky.social

The final day of #EANO2025 starts with the general assembly! Wonderful to see how well each committee is doing, thank you very much! @eanoassociation.bsky.social @galldiks.bsky.social @mj-mair.bsky.social @maxmastall.bsky.social @profajchalmers.bsky.social @jmwerner.bsky.social

Lively debates and sharp arguments at the #EANO2025 Youngsters Pro&Con Session - informative, entertaining, and full of expert insights, this is what scientific exchange should look like! #NeuroOncology @eanoassociation.bsky.social @maxmastall.bsky.social @galldiks.bsky.social

We had a brilliant #EANO2025 Youngsters and CBI session with countless helpful tricks for young investigators! @eanoassociation.bsky.social @maxmastall.bsky.social @mj-mair.bsky.social @galldiks.bsky.social @profajchalmers.bsky.social

The second day of EANO 2025 in Prague begins – featuring a full schedule of high-level science, clinical innovation, and exchange across all disciplines in #NeuroOncology.
See what’s on today 👉 eano.eu/eano2025/pro...

#Immuntherapy #Gliom #Neurosurgery #Youngsters #Radiotherapy #FamilyFocusedCare

The next day of #EANO2025 starts with many valuable insights from the EANO Youngsters-EORTC session on clinical trials! @eanoassociation.bsky.social

Today‘s sessions on intraoperative diagnostics and radiation therapy for gliomas at #EANO2025 were highly informative! @eanoassociation.bsky.social @profajchalmers.bsky.social

The opening plenary session at #EANO2025 highlighted some of the considerable advances made in the field! @eanoassociation.bsky.social

Storytelling matters! We had a great session about the importance of storytelling in #NeuroOncology at #EANO2025 @eanoassociation.bsky.social @mj-mair.bsky.social @maxmastall.bsky.social @galldiks.bsky.social

Last night‘s #EANO2025 reception was a blast - lots of opportunities to connect and reconnect with so many great people in the field! @eanoassociation.bsky.social @mj-mair.bsky.social @mj-mair.bsky.social @profajchalmers.bsky.social @apellerino85.bsky.social @galldiks.bsky.social

#EANO2025 is starting off strong with the Educational Day, featuring the clinical, basic science, and supportive care tracks! #NeuroOncology @eanoassociation.bsky.social @maxmastall.bsky.social @jmwerner.bsky.social @profajchalmers.bsky.social @apellerino85.bsky.social @galldiks.bsky.social

👉 We are very proud to present our #EANO2025 ambassadors! Follow them on LinkedIn a/o Bluesky for a range of expert insights & join the conversation using the official hashtag #EANO2025.
We look forward to meeting you all in #Prague!

#NeuroOncology #btsm

A mechanistic model of brain necrosis progression based on vascular heterogeneity Brain radionecrosis (RN) is a significant late toxicity of radiation therapy, yet its progression remains challenging to predict due to patient-specific factors. This study develops a mechanistic mode...

Excited to share our latest @ijrobp.bsky.social paper on modeling brain necrosis progression based on vascular heterogeneity! Huge congrats to the team for this accomplishment! @astro-org.bsky.social @estroradiotherapy.bsky.social @eanoassociation.bsky.social

www.redjournal.org/article/S036...

Had a fantastic time at #ASTRO2025 in San Francisco - grateful for the chance to reconnect with colleagues, collaborators, and friends from around the world! @astro-org.bsky.social @ucsfradonc.bsky.social @ruehlealex.bsky.social

The effect of TERT promoter mutation on predicting meningioma outcomes: a multi-institutional cohort analysis The indolent behaviour of certain TERTp-mutant meningiomas suggests that TERTp mutation is not sufficient to assign the most aggressive meningioma grade. Instead, TERT sequencing might offer prognosti...

Excited to share our latest work on TERT mutations in meningiomas, just published in @thelancetoncol.bsky.social! A huge thanks to the team! @neuroonc.bsky.social @eanoassociation.bsky.social @icomeningioma.bsky.social

www.thelancet.com/journals/lan...

Stereotactic Body Radiotherapy for the Treatment of Adrenal Metastases – A Case-Based Radiosurgery Society Practice Guide and Review Adrenal metastases are frequently diagnosed in patients with common solid tumors. Surgical adrenalectomy has historically been used for their management. However, stereotactic body radiotherapy (SBRT)...

Treating adrenal gland metastases with SBRT? Check out our latest guide - huge thanks to all collaborators! @estroradiotherapy.bsky.social @astro-org.bsky.social

www.practicalradonc.org/article/S187...

Impact of Extent of Resection on Survival in Brain... : Neurosurgery group. METHODS: We included patients who underwent BM resection and had postoperative MRI <72 hours. Presence of any residual on MRI was defined as subtotal resection (STR) as opposed to gross tota...

The extent of resection in brain metastases plays a critical role – but how impactful is it? Dive into our latest analysis, featuring data from 867 patients!

journals.lww.com/neurosurgery...

Radiosurgery for pediatric central nervous system lesions – initial report and insights from a multicenter registry Stereotactic radiosurgery (SRS) is an established treatment modality for a variety of benign and malignant central nervous system (CNS) lesions in adults [1,2]. However, data for its use in the pediat...

What’s the role of radiosurgery in pediatric patients with CNS lesions? Here’s our first multicenter study! @estroradiotherapy.bsky.social

www.thegreenjournal.com/article/S016...

Reirradiation with stereotactic radiosurgery for vestibular schwannomas – a systematic review and meta-analysis Vestibular schwannomas (VS), also known under the historical misnomer “acoustic neuroma”, are benign nerve sheath tumors that develop from the Schwann cells of the vestibular branch of the vestibuloco...

Reirradiation with SRS for vestibular schwannomas – how effective and safe is it? Check out our latest systematic review & meta-analysis! @estroradiotherapy.bsky.social

www.ctro.science/article/S240...

Early experience with proton craniospinal irradiation in adult patients with leptomeningeal disease - Radiation Oncology Background Leptomeningeal disease (LMD) is a fatal complication of cancer linked to poor survival rates and limited treatment options. While photon involved-field radiotherapy is the standard of care ...

Just published: Our early experience with proton CSI for LMD from solid tumors in adults - now online! @eanoassociation.bsky.social @neuroonc.bsky.social

doi.org/10.1186/s130...

ICOM member Spotlight: Dr. Felix Ehret

@felixehretmd.bsky.social is a research fellow at MGH and @harvardmed.bsky.social, as well as a #RadiationOncology resident @ChariteBerlin. His research focuses on refining and personalizing radiation therapy for various #BrainTumors, including gliomas, brain metastases, and #meningiomas.

Chromosome 1p Loss and 1q Gain for Grading of Meningioma This cohort study examines chromosomal copy number alterations that could be used to improve the current World Health Organization grading of meningioma

What do 1p losses and 1q gains mean for meningiomas? Read our latest study in JAMA Oncology! Huge thanks to everyone involved!

@gelarehzadeh.bsky.social @icomeningioma.bsky.social

jamanetwork.com/journals/jam...

As every year, the RSS annual meeting was a wonderful opportunity to connect with both old and new friends and collaborators!

The 2024 State of Science Report from the European Organisation for Research and Treatment of Cancer’s Radiation Oncology Scientific Council Radiotherapy (RT) is a central pillar of a multimodal cancer treatment approach. The ongoing advances in the fields of RT, imaging technologies, cancer biology, and others yield the potential to refin...

The EORTC 2024 ROSC State of Science Report is out! Huge thanks to all co-authors and contributors for their excellent work! @eortc.bsky.social

www.ejcancer.com/article/S095...

Stereotactic Radiosurgery for Vestibular Schwannoma – A Case-Based Practice Guide from the Radiosurgery Society Vestibular schwannomas (VS) are the most common benign intracranial nerve sheath tumors. Surgery and radiotherapy – particularly stereotactic radiosurgery (SRS) – are the primary treatment options. SR...

If you treat vestibular schwannomas with radiosurgery, this guide from The Radiosurgery Society is for you! Huge thanks to all collaborators! @eanoassociation.bsky.social @neuroonc.bsky.social @astro-org.bsky.social

www.practicalradonc.org/article/S187...

Pulmonary Stereotactic Body Radiotherapy of Oligometastatic Head-and-Neck Squamous Cell Carcinoma - A multicenter retrospective study The value of stereotactic body radiotherapy (SBRT) in patients with oligometastatic head-and-neck squamous cell carcinoma (HNSCC) remains unclear, as existing evidence is primarily derived from retros...

Here’s our multicenter analysis on SBRT for pulmonary metastases in oligometastatic head and neck cancer patients - A great collaborative effort!

www.redjournal.org/article/S036...